Lv1
46 积分 2023-10-31 加入
Oral Muvalaplin for Lowering of Lipoprotein(a)
17天前
已完结
Mechanistic Insights into Hybridization-Based Off-Target Activity of GalNAc-siRNA Conjugates
19天前
已完结
Considerations in the Immunogenicity Assessment Strategy for Oligonucleotide Therapeutics (ONTs)
1个月前
已完结
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已完结
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
1个月前
已完结
Targeting STING to promote antitumor immunity
1个月前
已完结
Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs
1个月前
已完结
Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review
2个月前
已完结
Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs
2个月前
已完结
Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma
3个月前
已完结
皖公网安备34019202002308
